Marco Donia, Research Group Leader of the TIL group at CCIT (Center for Cancer Immune Therapy) and Professor at the University of Copenhagen, shared a post on LinkedIn:
“Advancing Immuno-Oncology in South-Eastern Europe
The Bulgarian Scientific Society of Immuno-Oncology (BSSIO) is fostering an impressive environment for cancer immunotherapy, with clinicians and scientists working together to accelerate progress in a region with great potential.
It was a privilege to witness this energy at the 2025 Bulgarian National Immuno-Oncology Congress, and to join Prof. Georgi Momekov, in receiving honorary membership from Bulgarian Scientific Society of Immuno-Oncology (BSSIO).
Warm thanks to the society and to its President, Professor Jeliazko Arabadjiev, for the kind recognition and for his inspiring leadership to advance the field in this fast-evolving region.”
More posts featuring Marco Donia.